Company intelligence / Profile preview

Robles BioCeutics

San Diego, California, United Statesroblesbioceutics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Robles BioCeutics has developed Glowselle™, a stem cell-powered anti-aging skin cream that uses activated stem cell-derived products to promote skin regeneration. The company has filed a patent on its proprietary methodology involving "injury mimetics" which stimulate toll-like receptors to produce anti-aging products from stem cells.

Therapeutic areas: OtherDermatology
Modalities: Stem cell-derived productsExosomesGrowth factorsSenolytic technologies
Industry: Non-Drug Biotech

Drug pipeline

1 asset

Glowselle

Commercial

Indications: Skin aging, Wrinkles

Partnerships

BioCentrium

Beyond the preview

Go deeper on Robles BioCeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robles BioCeutics.

Explore the full profile